Last Updated: 09 Nov 2024
Executive Summary
Agilent Technologies Inc. (A) is a leading provider of analytical instrumentation and services to markets worldwide. The company has a strong financial position with a market capitalization of $39.27 billion, EBITDA of $1.56 billion, and EPS of $4.70. Agilent's stock is currently trading at $136.68, below its 52-week high of $154.82. The company's fundamentals are solid, with a trailing PE ratio of 29.08, a forward PE ratio of 24.39, and a dividend yield of 0.0068%. Agilent's technical analysis indicates that the stock is currently in a downtrend, but it is approaching a support level that could provide a buying opportunity.
Company Overview
Agilent Technologies Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. The company's products include instruments for measuring and testing electricity and electrical signals, as well as instruments for life sciences research. Agilent's customers include pharmaceutical companies, biotechnology companies, chemical companies, and environmental testing laboratories.
Fundamental Analysis
Agilent's financial performance has been strong in recent years. The company's revenue has grown at a CAGR of 5% over the past five years, and its EPS has grown at a CAGR of 10% over the same period. Agilent's profit margin is 21.7%, and its operating margin is 25%. The company's return on assets is 7.58%, and its return on equity is 24.7%.
Agilent's balance sheet is also strong. The company has $1.56 billion in cash and equivalents, and its debt-to-equity ratio is 0.56. Agilent's free cash flow is $1.2 billion, and its dividend payout ratio is 20%.
Technical Analysis
Agilent's stock price has been in a downtrend since reaching a 52-week high of $154.82 in January 2023. The stock is currently trading at $136.68, below its 50-day moving average of $139.57 and its 200-day moving average of $138.58. The stock's relative strength index (RSI) is 30.29, indicating that it is oversold.
Short Term Outlook
The technical analysis indicates that Agilent's stock is currently in a downtrend. However, the stock is approaching a support level at $135.00. If the stock can hold above this level, it could provide a buying opportunity.
Long Term Outlook
Agilent's long-term outlook is positive. The company's fundamentals are strong, and its products are in demand. The company is also well-positioned to benefit from the growing trend towards digital health and personalized medicine.
Analyst Recommendations
The majority of analysts have a buy rating on Agilent's stock. The average analyst target price is $148.81, which represents a potential upside of 9.0% from the current price.
